| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/23/2003 | EP1329457A2 Antipicornaviral compounds, their preparation and use |
| 07/23/2003 | EP1328512A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 07/23/2003 | CN1431996A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 07/23/2003 | CN1431995A Antipicornaviral compounds and compsns. their pharmaceutical uses, and materials for their synthesis |
| 07/23/2003 | CN1431994A Method for obtaining pure N-vinyl pyrrolidone |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/22/2003 | US6596902 Process for the preparation of 2-aryl-5- (perfluoro-alkyl)pyrrole compounds from N-[1-chloro-1-(perfluoroalkyl)methyl] arylimidoyl chloride compounds |
| 07/22/2003 | US6596879 Process for the synthesis of 1,3-diols |
| 07/22/2003 | US6596873 2-and 2,5-substituted phenylketoenols |
| 07/22/2003 | US6596754 Preventives/remedies for multiple organ failure |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders. |
| 07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
| 07/22/2003 | US6596706 For the treatment of circulatory diseases cerebral diseases |
| 07/22/2003 | US6596481 Dual markers |
| 07/17/2003 | WO2003057669A1 Androgen receptor antagonists |
| 07/17/2003 | WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057212A1 Polyamide derivatives possessing antibacterial, antifungal or antitumor activity |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057131A2 Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-[2-[ 4-[[[[(4-methyl cyclohexyl) amino]carbonyl] amino]sulfonyl] phenyl]ethyl] -2-oxo-1h-pyrrole -1-carboxamide |
| 07/17/2003 | WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 07/17/2003 | US20030135880 Compositions and methods for halogenation reactions |
| 07/17/2003 | US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics |
| 07/17/2003 | US20030134891 N,N'-bis(2-carboxytetramethylene)adipamide or cyclic alkylene esters for use in the treatment or prevention of central and systemic amyloidosis. |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors. |
| 07/17/2003 | US20030134802 Novel effectors of dipepetidyl peptidase IV |
| 07/17/2003 | CA2471754A1 Androgen receptor antagonist |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326834A2 2-substituted heterocyclic compounds |
| 07/16/2003 | EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326829A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1429815A Compound N-total trans dimension methanamide derivative and its preparation method and application |
| 07/16/2003 | CN1114477C Stable arylpyrrole particles, process for their preparation and suspension concentrate compositions comprising them |
| 07/15/2003 | USRE38188 Ethylene derivatives and pesticides containing said derivatives |
| 07/15/2003 | US6593474 Adrenergic blocking agents |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593312 Cyclic α-amino-γ-hydroxyamide compounds |
| 07/15/2003 | US6592631 Useful as developer compounds in oxidation dye compositions for keratin fibers. |
| 07/15/2003 | CA2218766C Bicyclic-aromatic compounds |
| 07/10/2003 | WO2003055859A1 Metal complexes of heterocyclic aromatic compounds |
| 07/10/2003 | WO2003055858A1 Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative |
| 07/10/2003 | WO2003055857A1 A process for synthesis of heterocyclic aminoalkyl benzamides |
| 07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| 07/10/2003 | WO2003055522A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 07/10/2003 | WO2003055441A2 Medicaments |
| 07/10/2003 | WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | US20030130523 Delivers more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood; substituted phenylacetanilides containing carboxyl group(s) |
| 07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
| 07/10/2003 | US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents |
| 07/10/2003 | US20030130307 Heterocycles |
| 07/10/2003 | US20030130281 DPP IV inhibitors |
| 07/10/2003 | US20030130275 Sulfonamide compounds with pharmaceutical activity |
| 07/10/2003 | US20030130272 Topoisomerase inhibitor; viricides |
| 07/10/2003 | US20030130256 Stimulant of central nervous system regeneration |
| 07/10/2003 | US20030130253 Central nervous system disorders; skin disorders; appetite suppressants |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130204 Antipicornaviral compounds and compositons, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | US20030130125 Pesticides; herbicides |
| 07/10/2003 | US20030127129 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound |
| 07/09/2003 | EP1325927A2 Synthesis of oligonucleotides |
| 07/09/2003 | EP1325910A1 Aliphatic nitrogenous five-membered ring compounds |
| 07/09/2003 | EP1324996A2 Substituted aryl ketones |
| 07/09/2003 | EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 07/09/2003 | EP1324983A1 Process for preparing distamycin derivatives |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | CN1429211A Method for processing pyrollidone and N-vinyl pyrollione residues |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/08/2003 | US6590115 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589964 Method for enhancing mutant enzyme activities in lysosomal storage disorders |
| 07/08/2003 | US6589962 Certain alpha -hydroxy- gamma -(((carbocyclic- or heterocyclic- substituted)amino)carbonyl)alkanamide derivatives are described as inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in |
| 07/08/2003 | US6589736 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 07/08/2003 | CA2256974C Bis (dialkylmaleimide) derivative and polyetherimide for optical communications formed therefrom |
| 07/03/2003 | WO2003053931A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | WO2003053924A1 Method for the continuous production of n-methyl-2-pyrrolidone (nmp) |
| 07/03/2003 | WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators |
| 07/03/2003 | WO2003053919A1 Substituted cyclohexane derivatives |
| 07/03/2003 | WO2003053918A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2003053368A2 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003035619A8 Tyrosine kinase inhibitors |
| 07/03/2003 | WO2002101073A3 Aryl-benzimidazole compounds having antiinfective activity |
| 07/03/2003 | US20030125590 For effecting reactions and/or separations using organic molecule, moiety or group having a domain or a portion thereof rich in carbon-fluorine bonds |
| 07/03/2003 | US20030125577 For detecting levels of urinary trypsin inhibitor in a biological sample; useful as an index of infection or inflammation |
| 07/03/2003 | US20030125570 Methods of making pyrrolidones |
| 07/03/2003 | US20030125548 Molecules derived from mechanism based drug design |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |